Embecta (Nasdaq:EMBC) to Discuss Q4 and Full Year 2025 Financial Results

PARSIPPANY, N.J. — November 11, 2025 — Leads & Copy — Embecta Corp. (Nasdaq: EMBC) will host a conference call to discuss its fiscal fourth quarter and full-year 2025 financial results and provide an operational update, including preliminary fiscal year 2026 financial guidance.

The call will take place at 8:00 a.m. Eastern Time (ET) on Tuesday, November 25, 2025.

Interested parties can access the live webcast here or the teleconference here. The live webcast will also be available on the company’s website.

A webcast replay will be available starting at 11:00 a.m. ET on November 25, 2025, on the embecta investor relations website and will be archived for one year.

Embecta is a global company building on its 100-year history in insulin delivery to become a broad-based medical supplies company. The company aims to improve lives through innovative solutions, partnerships, and the dedication of its approximately 2,000 employees worldwide.

Christian Glazar
Sr. Director, Corporate Communications
908-821-6922
Contact Media Relations

Pravesh Khandelwal
VP, Head of Investor Relations
551-264-6547
Contact IR

Source: embecta.com

×

Welcome!

BiotechReporter.news is a Leads & Copy Publication

Leads & Copy is a Media “news tip” source, providing Industry Reporters story Leads, written as Publishable CP-style Copy.

By Subscribing you will receive Daily Biotech Story Leads via email 10:30 am Mon-Fri.